Tempus AI, Inc. (NASDAQ: TEM - Get Free Report) CEO Ryan Fukushima sold 700 shares of the firm's sto

Tempus AI, Inc. (NASDAQ: TEM - Get Free Report) CAO Ryan Bartolucci sold 7,062 shares of the company

Tempus AI, Inc. (NASDAQ: TEM - Get Free Report) EVP Andrew Polovin sold 2,951 shares of the firm's s

Tempus AI stock pulled back Friday but stays firmly above key moving averages. Is the TEM rally stil

Tempus AI stock continues its strong bull run and is now trading at its highest level since November

Tempus (TEM) saw its shares surge in the last session with trading volume being higher than average.

Wall Street snapped a two-day losing streak Thursday as oil retreated from its geopolitical spike an

U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal.

Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Novo Nordisk taps Anthropic AI to speed medicine research, enhance software workflows, and implement

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p

Tempus AI, Inc. (TEM) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Eric Lefkofsky, Tempus AI founder and CEO, joins 'The Exchange' to discuss AI's role in healthcare,

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14,

Tempus CEO Eric Lefkofsky discusses the company's artificial intelligence-driven precision medicine

Tempus AI, Inc. (NASDAQ: TEM) today announced an initiative to build a research platform containing

On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Manage

CNBC’s final trades: Joshua Brown picked Snowflake, Bill Baruch chose Tempus AI, Malcolm Ethridge fa

The Initiative Will Make Available 100,000 Disease-Specific Whole Genome Sequences Paired with Longi

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced an initiative to build a res

HC Wainwright & Co. analyst Yi Chen maintains Tempus AI (NASDAQ:TEM) with a Buy and raises th

Tempus AI, Inc. (NASDAQ: TEM) today announced that it has been selected by the Advanced Research Pro

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced that it has been selected by

UBS analyst Doug Schenkel initiates coverage on Tempus AI (NASDAQ:TEM) with a Neutral rating and

Rothschild & Co analyst Jamie Clark initiates coverage on Tempus AI (NASDAQ:TEM) with a Neutr

Roth Capital analyst Jamie Clark initiates coverage on Tempus AI (NASDAQ:TEM) with a Neutral rati

Tempus AI, Inc. (NASDAQ: TEM) today announced that Founder and CEO Eric Lefkofsky will participate i

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced that Founder and CEO Eric Le

Tempus AI receives an Overweight rating and $80 price target from Cantor Fitzgerald, which sees sign

Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments

The disposition involved 3,000 shares executed at $69.00 per share, totaling $207,000 in transaction

Cantor Fitzgerald analyst Sarah James initiates coverage on Tempus AI (NASDAQ:TEM) with a Overwei

Ark Invest sold $15.6 million of Tempus AI and $3.4 million of AMD on Tuesday, Sept. 1, 2026.

Piper Sandler analyst David Westenberg upgrades Tempus AI (NASDAQ:TEM) from Neutral to Overweight

The biotech sector has a new catalyst beyond GLP-1 drugs. Moderna Inc (NASDAQ:MRNA) and Merck & Co I

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the fu

Freedom Capital Markets analyst Gene Mannheimer maintains Tempus AI (NASDAQ:TEM) with a Hold and

Ark Invest bought roughly $17 million in Cerebras shares Tuesday, Aug. 25, 2026, while trimming its

Tempus AI stock pulls back after a 20% surge as cancer data spotlights its Personalis deal, and FDA

US equities mixed as tech stocks drag Nasdaq 100 lower, Trump escalates trade fight with Canada, and

Tempus AI, Inc. (NASDAQ:TEM) today announced it has received 510(k) clearance from the U.S. Food and

Tempus AI is trading higher Friday as traders digest the latest follow-through from this week’s Merc

Long-end Treasury yields snapped back toward 20-month highs; Walmart posted its worst session in fou

Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX,

Tempus AI (TEM) trades higher after positive Phase 3 mRNA cancer trial results spotlight its $1.5B a

BTIG analyst Mark Massaro maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price target

Healthcare stocks saw mixed after-hours moves, with Moderna and Merck cooling after explosive gains

Treasury's expanded long-bond buybacks knocked yields off 20-month highs and sank the dollar, as

Shares of Tempus AI are surging Wednesday morning as traders connected the dots between a landmark c